CCEL
CryoCell International Inc
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.2% | 15.4% | 15.3% | 16.2% | 16.9% | 19.4% | 19.4% | 20.3% | 18.5% | 19.0% | 18.2% | 18.6% | |
| 0.8% | 0.7% | 0.4% | 0.7% | 0.3% | 0.9% | 0.3% | 0.2% | 0.4% | 0.5% | 0.4% | 0.8% | |
| 1.7% | 1.6% | 1.6% | 2.4% | 3.4% | 5.4% | 5.4% | 6.9% | 5.1% | 5.3% | 4.8% | 5.2% | |
| 9.2% | 10.7% | 10.9% | 10.9% | 10.9% | 11.3% | 11.2% | 10.8% | 10.8% | 11.1% | 11.2% | 11.4% | |
| 1.5% | 1.3% | 1.2% | 1.1% | 1.2% | 1.0% | 1.1% | 1.1% | 1.0% | 0.7% | 0.6% | 0.5% | |
| 28.6% | – | – | – | – | – | – | – | – | – | – | – | |
| 2.8% | 3.2% | 3.1% | 3.1% | 3.1% | 3.0% | 3.0% | 3.0% | 3.1% | 3.1% | 3.2% | 3.2% | |
| 20.6% | 1.6% | 1.6% | 1.5% | 1.5% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | 1.4% | |
| 100.0% | 118.0% | 116.8% | 117.2% | 115.2% | 120.4% | 122.8% | 124.1% | 123.5% | 130.1% | 130.2% | 129.3% | |
| 26.6% | 34.1% | 31.4% | 31.1% | 27.7% | 33.4% | 33.7% | 33.8% | 29.2% | 32.1% | 29.2% | 26.2% | |
| 4.5% | 2.6% | 3.9% | 7.5% | 4.4% | 6.4% | 8.1% | 11.3% | 5.8% | 4.7% | 3.3% | 1.0% | |
| 4.0% | 5.2% | 4.9% | 2.9% | 3.2% | 2.9% | 4.3% | 3.5% | 4.1% | 4.7% | 5.4% | 4.7% | |
| 12.1% | 13.8% | 13.6% | 13.4% | 13.2% | 12.8% | 12.9% | 12.8% | – | 13.2% | 13.3% | 13.3% | |
| 0.0% | -18.0% | -16.8% | -17.2% | -15.2% | -20.4% | -22.8% | -24.1% | -23.5% | -30.1% | -30.2% | -29.3% | |
| -28.6% | -50.9% | -49.6% | -47.9% | -45.9% | -50.7% | -53.6% | -54.9% | -54.8% | -62.3% | -63.1% | -62.3% | |
| 12.0% | 13.6% | 13.4% | 13.2% | 13.0% | 12.7% | 12.7% | 12.6% | 12.8% | 13.1% | 13.2% | 13.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.